DocuSign director Wilderotter sells 1,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
DocuSign, Inc. director Mary Agnes Wilderotter sold 1,000 shares of common stock on October 1, 2026, at $68.80 per share pursuant to a Rule 10b5-1 plan she adopted. She directly held 2,199 shares after the sale.
Insider Trade Summary 10b5-1
Net Seller: 1,000 shares
Net Sell
1 txn
Insider
Wilderotter Mary Agnes
Role
Director
Sold
1,000 shs ($69K)
Share of Position Sold
31.3%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 1,000 | $68.80 | $69K |
Holdings After Transaction:
Common Stock — 2,199 shares (Direct)
Holdings Before and After:
Common Stock, 3,199 to 2,199 shares (Direct)
Other Insiders: 8 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (1)
- F1. The transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
Key Figures
Shares sold: 1,000 shares
Sale price: $68.80 per share
Direct shares after sale: 2,199 shares
3 metrics
Shares sold
1,000 shares
October 1, 2026
Sale price
$68.80 per share
October 1, 2026
Direct shares after sale
2,199 shares
Following the October 1, 2026 sale
Key Terms
Rule 10b5-1 plan
1 terms
Rule 10b5-1 plan regulatory
"pursuant to a Rule 10b5-1 plan adopted by the Reporting Person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.